Melissa Johnson, MD

English

Dr. Johnson is a board-certified medical oncologist at SCRI Oncology Partners and the director of lung cancer research at SCRI. After completing her medical education and training, Dr. Johnson spent four years as a faculty member at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and Feinberg School of Medicine, where she was also a founding member of the Northwestern Medical Developmental Therapeutics Institute. She is dedicated to advancing lung cancer research and works in early-phase cancer drug development, as well as solid tumor immune effector cellular therapy.

Dr. Johnson is dedicated to the advancement of individualized yet comprehensive cancer care. She strives to provide each patient with leading-edge treatment that meets their unique needs. She works closely with a multidisciplinary team of experts to define each patient’s cancer treatment plan and emphasizes continuous communication among the treatment team throughout its execution.